For: | Di Marco M, Grassi E, Durante S, Vecchiarelli S, Palloni A, Macchini M, Casadei R, Ricci C, Panzacchi R, Santini D, Biasco G. State of the art biological therapies in pancreatic cancer. World J Gastrointest Oncol 2016; 8(1): 55-66 [PMID: 26798437 DOI: 10.4251/wjgo.v8.i1.55] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v8/i1/55.htm |
Number | Citing Articles |
1 |
Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Francesco Cellini, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Alessio Giuseppe Morganti, Vincenzo Valentini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Vito Lorusso, Michele Reni, Stefano Cascinu. Multimodal treatment of resectable pancreatic ductal adenocarcinoma. Critical Reviews in Oncology/Hematology 2017; 111: 152 doi: 10.1016/j.critrevonc.2017.01.015
|
2 |
Xinjian Liu, Hao Yuan, Jing Zhou, Qiongling Wang, Xiaoqiang Qi, Catharine Bernal, Diego Avella, Jussuf T. Kaifi, Eric T. Kimchi, Parrett Timothy, Kun Cheng, Yi Miao, Kuirong Jiang, Guangfu Li. LMO7 as an Unrecognized Factor Promoting Pancreatic Cancer Progression and Metastasis. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.647387
|
3 |
Guo Chen, Haiyang Song, Zelong Yang, Tianshu Du, Yu Zheng, Zifan Lu, Kunpeng Zhang, Di Wei. AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.890193
|
4 |
Eileen M. O’Reilly, Do-Youn Oh, Neesha Dhani, Daniel J. Renouf, Myung Ah Lee, Weijing Sun, George Fisher, Aram Hezel, Shao-Chun Chang, Gordana Vlahovic, Osamu Takahashi, Yin Yang, David Fitts, Philip Agop Philip. Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma. JAMA Oncology 2019; 5(10): 1431 doi: 10.1001/jamaoncol.2019.1588
|
5 |
Omer Hanif, Zhu Donghua, Wang Xuefeng, M. Saqib Nawaz. Refining the Measurement of Topic Similarities Through Bibliographic Coupling and LDA. IEEE Access 2019; 7: 179997 doi: 10.1109/ACCESS.2019.2958489
|
6 |
Radim Moravec, Rao Divi, Mukesh Verma. Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression. World Journal of Gastrointestinal Oncology 2017; 9(6): 235-250 doi: 10.4251/wjgo.v9.i6.235
|
7 |
Yu-Ting Fang, Wen-Wei Yang, Ya-Ru Niu, Yong-Kun Sun. Recent advances in targeted therapy for pancreatic adenocarcinoma. World Journal of Gastrointestinal Oncology 2023; 15(4): 571-595 doi: 10.4251/wjgo.v15.i4.571
|
8 |
JINGMEI LUO, LI YU, GUANGCHENG XIE, DAN LI, MENG SU, XUERONG ZHAO, LUANYING DU. Study on the mitochondrial apoptosis pathways of small cell lung cancer H446 cells induced by Trichinella spiralis muscle larvae ESPs. Parasitology 2017; 144(6): 793 doi: 10.1017/S0031182016002535
|
9 |
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer. 2014; : 1 doi: 10.1007/978-3-642-27841-9_4358-4
|
10 |
Yong An, Xue-min Chen, Yong Yang, Feng Mo, Yong Jiang, Dong-lin Sun, Hui-hua Cai. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0643-7
|
11 |
Hadas Gibori, Shay Eliyahu, Adva Krivitsky, Dikla Ben-Shushan, Yana Epshtein, Galia Tiram, Rachel Blau, Paula Ofek, Joo Sang Lee, Eytan Ruppin, Limor Landsman, Iris Barshack, Talia Golan, Emmanuelle Merquiol, Galia Blum, Ronit Satchi-Fainaro. Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer. Nature Communications 2018; 9(1) doi: 10.1038/s41467-017-02283-9
|
12 |
Stefania Cannone, Maria Raffaella Greco, Tiago M. A. Carvalho, Helene Guizouarn, Olivier Soriani, Daria Di Molfetta, Richard Tomasini, Katrine Zeeberg, Stephan Joel Reshkin, Rosa Angela Cardone. Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition. Cancers 2022; 14(15): 3737 doi: 10.3390/cancers14153737
|
13 |
M. Bupathi, D. H. Ahn, C. Wu, K. K. Ciombor, J. A. Stephens, J. Reardon, D. A. Goldstein, T. Bekaii-Saab. Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience. Medical Oncology 2016; 33(4) doi: 10.1007/s12032-016-0753-9
|
14 |
Matineh Barati Bagherabad, Fahimeh Afzaljavan, Soodabeh ShahidSales, Seyed Mahdi Hassanian, Amir Avan. Targeted therapies in pancreatic cancer: Promises and failures. Journal of Cellular Biochemistry 2019; 120(3): 2726 doi: 10.1002/jcb.26284
|
15 |
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer. 2014; : 3421 doi: 10.1007/978-3-662-46875-3_4358
|
16 |
Douglas K. Brubaker, Joao A. Paulo, Shikha Sheth, Emily J. Poulin, Olesja Popow, Brian A. Joughin, Samantha Dale Strasser, Alina Starchenko, Steven P. Gygi, Douglas A. Lauffenburger, Kevin M. Haigis. Proteogenomic Network Analysis of Context-Specific KRAS Signaling in Mouse-to-Human Cross-Species Translation. Cell Systems 2019; 9(3): 258 doi: 10.1016/j.cels.2019.07.006
|
17 |
Mohamed El-Tanani, Hamdi Nsairat, Ismail I. Matalka, Alaa A. A. Aljabali, Vijay Mishra, Yachana Mishra, Gowhar A. Naikoo, Sai Raghuveer Chava, Nitin B. Charbe, Murtaza M. Tambuwala. Impact of exosome therapy on pancreatic cancer and its progression. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02101-x
|
18 |
Catherine S. Wegner, Anette Hauge, Jon-Vidar Gaustad, Lise Mari K. Andersen, Trude G. Simonsen, Kanthi Galappathi, Einar K. Rofstad. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts. Acta Oncologica 2017; 56(12): 1754 doi: 10.1080/0284186X.2017.1343494
|
19 |
Alexandr V. Bazhin, Katharina von Ahn, Jasmin Fritz, Henriette Bunge, Caroline Maier, Orkhan Isayev, Florian Neff, Jens T. Siveke, Svetlana Karakhanova. Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer. OncoImmunology 2022; 11(1) doi: 10.1080/2162402X.2022.2043037
|
20 |
Giuseppe Tridente. Adverse Events and Oncotargeted Kinase Inhibitors. 2017; : 145 doi: 10.1016/B978-0-12-809400-6.00007-X
|
21 |
Hongjuan Yao, Wenping Song, Rui Cao, Cheng Ye, Li Zhang, Hebing Chen, Junting Wang, Yuchen Shi, Rui Li, Yi Li, Xiujun Liu, Xiaofei Zhou, Rongguang Shao, Liang Li. An EGFR/HER2-targeted conjugate sensitizes gemcitabine-sensitive and resistant pancreatic cancer through different SMAD4-mediated mechanisms. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-33037-x
|
22 |
Nicole Lintern, Andrew M. Smith, David G. Jayne, Yazan S. Khaled. Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(16): 4135 doi: 10.3390/cancers15164135
|
23 |
Indraneil Mukherjee, Brett Powell, Mary Parianos, Darrell Downs, Sharona B. Ross. Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer. Cancer Genetics 2016; 209(12): 582 doi: 10.1016/j.cancergen.2016.08.001
|
24 |
Célia Cintas, Thibaut Douché, Nicole Therville, Silvia Arcucci, Fernanda Ramos-Delgado, Céline Basset, Benoît Thibault, Julie Guillermet-Guibert. Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. Cancers 2018; 10(6): 174 doi: 10.3390/cancers10060174
|
25 |
Giulia Biondani, Katrine Zeeberg, Maria Raffaella Greco, Stefania Cannone, Ilaria Dando, Elisa Dalla Pozza, Maria Mastrodonato, Stefania Forciniti, Valeria Casavola, Marta Palmieri, Stephan Joel Reshkin, Rosa Angela Cardone. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome. The FEBS Journal 2018; 285(11): 2104 doi: 10.1111/febs.14471
|
26 |
Zilong Zhang, Jin Shang, Zonglin Dai, Yutong Yao, Ying Shi, Deyuan Zhong, Yuxin Liang, Chunyou Lai, Qinyan Yang, Tianhang Feng, Xiaolun Huang. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.848391
|